Strs Ohio Has $197,000 Position in Avantor, Inc. $AVTR

Strs Ohio cut its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 97.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,797 shares of the company’s stock after selling 579,993 shares during the period. Strs Ohio’s holdings in Avantor were worth $197,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in AVTR. Voss Capital LP bought a new stake in shares of Avantor during the 2nd quarter valued at about $6,057,000. ABS Direct Equity Fund LLC acquired a new position in Avantor in the third quarter valued at approximately $1,248,000. Tredje AP fonden boosted its holdings in shares of Avantor by 110.7% during the 2nd quarter. Tredje AP fonden now owns 110,981 shares of the company’s stock worth $1,494,000 after buying an additional 58,304 shares in the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Avantor during the 2nd quarter worth approximately $2,055,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Avantor in the 3rd quarter valued at $1,208,000. 95.08% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Sanjeev K. Mehra purchased 350,000 shares of the firm’s stock in a transaction dated Friday, December 5th. The stock was bought at an average price of $11.09 per share, for a total transaction of $3,881,500.00. Following the purchase, the director directly owned 350,000 shares in the company, valued at approximately $3,881,500. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.20% of the stock is currently owned by insiders.

Avantor Price Performance

Shares of NYSE:AVTR opened at $11.08 on Tuesday. The company has a market capitalization of $7.55 billion, a P/E ratio of -85.19, a price-to-earnings-growth ratio of 3.78 and a beta of 0.94. The company’s 50-day moving average is $11.57 and its 200 day moving average is $12.39. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.96 and a current ratio of 1.49. Avantor, Inc. has a fifty-two week low of $10.62 and a fifty-two week high of $22.44.

Analysts Set New Price Targets

Several research analysts recently issued reports on AVTR shares. Evercore ISI set a $12.00 target price on shares of Avantor and gave the stock an “in-line” rating in a research note on Monday, January 5th. UBS Group set a $12.00 target price on Avantor in a research note on Thursday, October 30th. Raymond James Financial lowered Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. TD Cowen cut their price target on Avantor from $14.00 to $12.00 and set a “hold” rating on the stock in a report on Wednesday, January 7th. Finally, Robert W. Baird boosted their price objective on Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.60.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.